GenMont Biotech (TPE:3164) GF Score: 83/100 (As of Jul. 11, 2026) — 20% Above Median


TPE:3164 GenMont Biotech Inc TPE:3164
83 GF Score
Price NT$16.45
GF Value NT$26.24
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GenMont Biotech GF Score?

GenMont Biotech TPE:3164 83 GF Score is 83 as of Jul. 11, 2026, which is 20% above its 10-year median of 69.00. GuruFocus rates TPE:3164 with a GF Score™ of 83/100 and a GF Value™ of NT$26.24 (Significantly Undervalued). The stock has 5 warning signs investors should review.

GenMont Biotech has the GF Score of 83, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 7/10
3. Growth Rank : 8/10
4. GF Value Rank : 4/10
5. Momentum Rank : 6/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes GenMont Biotech might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

GenMont Biotech  (TPE:3164) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

GenMont Biotech GF Score Related Terms

TPE:3164 vs VRTX, REGN, ALNY: GF Score Comparison

For the Biotechnology subindustry, GenMont Biotech's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GenMont Biotech GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GenMont Biotech's GF Score distribution charts can be found below:

* The bar in red indicates where GenMont Biotech's GF Score falls into.


TPE:3164
83GF Score
GenMont Biotech Inc TPE:3164
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 83 mean?
GenMont Biotech (TPE:3164) has a GF Score of 83 as of Jul. 11, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on GenMont Biotech and its competitors. This is 20% above median its historical median of 69.00. Over the past decade, GenMont Biotech's GF Score has ranged from 29.00 to 83.00.
Is GenMont Biotech's GF Score too high?
GenMont Biotech's current GF Score of 83 is 20% above median its 10-year median of 69.00. Over the past 10 years, this metric has ranged from a low of 29.00 to a high of 83.00. Overall, GenMont Biotech has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's GF Score compare to VRTX and REGN?
GenMont Biotech's GF Score of 83 can be compared against companies in the Biotechnology industry. Historically, GenMont Biotech's own GF Score has ranged from 29.00 to 83.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on GenMont Biotech and its competitors. GenMont Biotech's current GF Score is 83, which is 20% above median its own 10-year median of 69.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$26.24, compared to a current price of NT$16.45 — trading 37.3% below its estimated fair value. The current GF Score is 83, which is 20% above median its 10-year median of 69.00. GenMont Biotech's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current GF Score is 83 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GenMont Biotech (TPE:3164) Overvalued in 2026?

Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued. The current stock price of NT$16.45 is trading 37.3% below its estimated GF Value™ of NT$26.24. GuruFocus considers GenMont Biotech to be Significantly Undervalued.

Key valuation signals for TPE:3164:

  • GF Score: 83 (20% above median its 10-year median of 69.00)
  • GF Value™: NT$26.24 vs. price of NT$16.45 (37.3% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GenMont Biotech Business Description

Address No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741014
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
83GF Score

Get the complete analysis for TPE:3164

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.45
Price
NT$26.24
GF Value